As of Mar 04
| -0.05 / -0.62%|
The 1 analysts offering 12-month price forecasts for MusclePharm Corp have a median target of 22.00, with a high estimate of 22.00 and a low estimate of 22.00. The median estimate represents a +173.29% increase from the last price of 8.05.
The current consensus among 1 polled investment analysts is to Buy stock in MusclePharm Corp. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.